Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 16 results.
User Information
Export Records
  1. 1.   Quantitative imaging for development of companion diagnostics to drugs targeting HGF/MET
  2. Huang, F.; Ma, Z.; Pollan, S.; Yuan, X.; Swartwood, S.; Gertych, A.; Rodriguez, M.; Mallick, J.; Bhele, S.; Guindi, M.; Dhall, D.; Walts, A. E.; Bose, S.; de Peralta Venturina, M.; Marchevsky, A. M.; Luthringer, D. J.; Feller, S. M.; Berman, B.; Freeman, M. R.; Alvord, W. G.; Vande Woude, G.; Amin, M. B.; Knudsen, B. S.
  3. The journal of pathology. Clinical research. 2016, Oct; 2(4): 210-222.
  1. 2.   Radiosensitization of glioma cells by modulation of Met signalling with the hepatocyte growth factor neutralizing antibody, AMG102
  2. Buchanan, I. M.; Scott, T.; Tandle, A. T.; Burgan, W. E.; Burgess, T. L.; Tofilon, P. J.; Camphausen, K.
  3. Journal of Cellular and Molecular Medicine. 2011, Sep; 15(9): 1999-2006.
  1. 3.   Matriptase/epithin participates in mammary epithelial cell growth and morphogenesis through HGF activation
  2. Lee, S. L.; Huang, P. Y.; Roller, P.; Cho, E. G.; Park, D.; Dickson, R. B.
  3. Mechanisms of Development. 2010, Jan-Feb; 127(1-2): 82-95.
  1. 4.   Oncogenic met receptor induces cell-cycle progression in Xenopus oocytes independent of direct Grb2 and shc binding or Mos synthesis, but requires phosphatidylinositol 3-kinase and Raf signaling
  2. Mood, K.; Saucier, C.; Ishimura, A.; Bong, Y. S.; Lee, H. S.; Park, M.; Daar, I. O.
  3. Journal of Cellular Physiology. 2006, APR; 207(1): 271-285.
  1. 5.   C/EBP alpha deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo
  2. Heath, V.; Suh, H. C.; Holman, M.; Renn, K.; Gooya, J. M.; Parkin, S.; Klarmann, K. D.; Ortiz, M.; Johnson, P.; Keller, J.
  3. Blood. 2004, SEP 15; 104(6): 1639-1647.
  1. 6.   Ex vivo and in vivo biological effects of a truncated form of the receptor tyrosine kinase Stk when activated by interaction with the friend spleen focus-forming virus envelope glycoprotein or by point mutation
  2. Rulli, K.; Yugawa, T.; Hanson, C.; Thompson, D.; Ruscetti, S.; Nishigaki, K.
  3. Journal of Virology. 2004 78(9): 4573-4581.
  1. 7.   Cross-talk between RON receptor tyrosine kinase and other transmembrane receptors
  2. Danilkovitch-Miagkova, A.; Leonard, E. J.
  3. Histology and Histopathology. 2001 16(2): 623-631.
  1. 8.   Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway
  2. Danilkovitch-Miagkova, A.; Miagkov, A.; Skeel, A.; Nakaigawa, N.; Zbar, B.; Leonard, E. J.
  3. Molecular and Cellular Biology. 2001 21(17): 5857-5868.
  1. 9.   Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells
  2. Firon, M.; Shaharabany, M.; Altstock, R. T.; Horev, J.; Abramovici, A.; Resau, J. H.; Vande Woude, G. F.,; Tsarfaty, I.
  3. Oncogene. 2000 19(20): 2386-2397.
  1. 10.   Comparison of c-met expression in ovarian epithelial tumors and normal epithelia of the female reproductive tract by quantitative laser scan microscopy
  2. Huntsman, D.; Resau, J. H.; Klineberg, E.; Auersperg, N.
  3. American Journal of Pathology. 1999 155(2): 343-348.
  1. 11.   Alteration of Met protooncogene product expression and prognosis in breast carcinomas
  2. Tsarfaty, I.; Alvord, W. G.; Resau, J. H.; Altstock, R. T.; Lidereau, R.; Bieche, I.; Bertr, F.; Horev, J.; Klabansky, R. L.; Keydar, I.; Vande Woude, G. F.
  3. Analytical and Quantitative Cytology and Histology. 1999 21(5): 397-408.
  1. 12.   The Solution Structure of the N-Terminal Domain of Hepatocyte Growth Factor Reveals a Potential Heparin-Binding Site
  2. Zhou, H. J.; Mazzulla, M. J.; Kaufman, J. D.; Stahl, S. J.; Wingfield, P. T.; Rubin, J. S.; Bottaro, D. P.; Byrd, R. A.
  3. Structure. 1998 6(1): 109-116.
  1. 13.   Evidence For a Role of Met-Hgf/Sf During Ras-Mediated Tumorigenesis/Metastasis
  2. Webb, C. P.; Taylor, G. A.; Jeffers, M.; Fiscella, M.; Oskarsson, M.; Resau, J. H.; Woude, G. F. V.
  3. Oncogene. 1998 17(16): 2019-2025.
  1. 14.   Decreased Fibronectin Expression in Met/Hgf-Mediated Tumorigenesis
  2. Taylor, G. A.; Jeffers, M.; Webb, C. P.; Koo, H. M.; Anver, M.; Sekiguchi, K.; Woude, G. F. V.
  3. Oncogene. 1998 17(9): 1179-1183.
  1. 15.   Diverse Tumorigenesis Associated With Aberrant Development in Mice Overexpressing Hepatocyte Growth Factor Scatter Factor
  2. Takayama, H.; Larochelle, W. J.; Sharp, R.; Otsuka, T.; Kriebel, P.; Anver, M.; Aaronson, S. A.; Merlino, G.
  3. Proceedings of the National Academy of Sciences of the United States of America. 1997 94(2): 701-706.
  1. 16.   Gene Structure of the Human Met Proto-Oncogene
  2. Duh, F. M.; Scherer, S. W.; Tsui, L. C.; Lerman, M. I.; Zbar, B.; Schmidt, L.
  3. Oncogene. 1997 15(13): 1583-1586.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel